Research we delivered
Hawthorne Health supported the Cardiovascular Research Foundation on PREVUE-VALVE. We contacted eligible individuals to obtain informed consent and schedule the study procedures, and our sonographers performed the echocardiograms in participants’ homes, in all 50 states, to the core laboratory’s acquisition protocol.
An independent research organization (Hawthorne Health) then contacted eligible individuals to obtain informed consent and schedule the study procedures.
PREVUE-VALVE, Methods
Earlier prevalence studies drew on people who already had a clinical reason for an echocardiogram, or who were well enough to travel to a medical facility. This one went to the participants instead, and the authors conclude it establishes the feasibility of large-scale decentralized cardiovascular imaging.
The investigators thank Michael Arevelo, Ah’Shirae Arana, and Caroline Callison of Hawthorne Health in the paper’s acknowledgments.
Brener MI, et al. Senior author: Cohen DJ. Population Prevalence of Valvular Heart Disease in the United States: The PREVUE-VALVE Study Journal of the American College of Cardiology. J Am Coll Cardiol. 2026;87(23):3227-3239. doi:10.1016/j.jacc.2026.02.5137 (NCT05357404)
Our investigators' own research
These are the investigators' own publication records, most of it work done before they joined the network, taken from the curricula vitae we hold. Per-investigator bibliographies are shared with sponsors and CROs on request rather than published here.
Peer-reviewed journal articles only. Book chapters, conference abstracts, posters, letters and trade pieces are excluded. An investigator absent from this count has no publications section in any CV we hold, which is not the same as having none.
In the media
Coverage only. Our own announcements are in the newsroom.
Clinical Leader · May 21, 2026
A feature on whether research embedded in independent community pharmacies can do what the retail chains could not, built around a conversation with Josh Rose.
Dan Schell, Chief Editor
Read it at Clinical LeaderI don’t view us as DCT at all. Take any site network — it’s physical locations, brick and mortar.
Josh Rose, Chief Executive Officer
Industry recognition
Society for Clinical Research Sites · August 24, 2026
One of three finalists, for a model that puts research inside community pharmacies and supports patients with a nationwide at-home visit network.
Society for Clinical Research Sites · June 13, 2025
A standing collaboration with SCRS on site sustainability and patient access.
Invited to present
Xtalks · August 21, 2026
A webinar on how community sites and at-home visits change who is able to take part in research.
Evaluate the network for your study
We will come back with a clear view of fit, coverage, and a recommended delivery approach.
